PROCAPS GROUP SA (PROC)
LU2376511205 - Common Stock
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated...
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
MIAMI and BARRANQUILLA, Colombia , Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced today...
Procaps Issues Shareholder Letter Update
Procaps Issues Shareholder Letter Update
MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated...
Procaps Issues Shareholder Letter Update
Procaps Issues Shareholder Letter Update
MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
Procaps Issues Shareholder Letter
Procaps Issues Shareholder Letter
MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Procaps Group Announces New Chairman
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
Procaps Issues Shareholder Letter from New CEO
Procaps Group – Notice to Shareholders
Procaps Group reports Q3 results; updates FY23 outlook (NASDAQ:PROC)
Procaps Group press release (PROC): Q3 Adjusted EBITDA was $22 million in 3Q23, with an Adjusted EBITDA margin of 19%. Revenue of $118M (+7.3% Y/Y) beats by $7.4M.
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
PROC stock results show that Procaps Gr beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Procaps Gr (NASDAQ:PROC) just reported results for the third quarter of 2023.Pr...
Procaps Group Reports Third Quarter 2023 Results
Statement from the Board of Directors of Procaps Group
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America
/PRNewswire/ -- Procaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab...
Procaps Group says CEO Minski to step down from the role (NASDAQ:PROC)
Procaps Group announces CEO transition as Ruben Minski steps down after 45 years.
